Author: Minichart

us corporate news

W. P. Carey Inc. Announces $580 Million Q1 2026 Investment Volume and Business Update

Minichart

March 31, 2026

W. P. Carey Inc. Q1 2026 Investment and Financing Update: Ke...

Continue Reading 0

us corporate news

BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita, Focusing on Home Health and Pharmacy Services 1

Minichart

March 31, 2026

BrightSpring Health Services Completes Strategic Sale of Res...

Continue Reading 0

us corporate news

Realty Income Corporation Prices $800 Million 4.750% Notes Due 2033 – Offering Details and Underwriters List 198085

Minichart

March 31, 2026

Realty Income Corporation Issues \$800 Million of 4.750% Not...

Continue Reading 0

us corporate news

Caring Brands, Inc. Appoints Interim CFO and Amends Bylaws – SEC Form 8-K Filing March 2026

Minichart

March 31, 2026

Caring Brands, Inc. - Detailed Investor Update (8-K Filing, ...

Continue Reading 0

us corporate news

Galectin Therapeutics Reports 2025 Financial Results, Advances Belapectin Program for MASH Cirrhosis, and Extends Cash Runway Through 2027

Minichart

March 31, 2026

Galectin Therapeutics 2025 Financial Results & Business Upda...

Continue Reading 0

us corporate news

KeyBank and Lenders Establish Credit Agreement with Cintas Corporation – Terms, Definitions, and Financial Covenants Explained

Minichart

March 31, 2026

Cintas Corporation No. 2 - Credit Agreement and Material Eve...

Continue Reading 0

us corporate news

IO Biotech, Inc. Files Form 8-K With SEC – Company Information, Stock Details, and Regulatory Compliance (March 31, 2026)

Minichart

March 31, 2026

IO Biotech, Inc. Files for Chapter 7 Bankruptcy and Ceases O...

Continue Reading 0

us corporate news

Entrepreneur Universe Bright Group Reports 2025 Financial Results: 7.7% Revenue Growth and Strategic Expansion Plans

Minichart

March 31, 2026

Entrepreneur Universe Bright Group Reports Full Year 2025 Re...

Continue Reading 0

us corporate news

Palvella Therapeutics Announces Positive Phase 3 Results for QTORIN Rapamycin, Prepares NDA Submission and U.S. Launch for Rare Skin Disease Therapies

Minichart

March 31, 2026

Palvella Therapeutics Announces Landmark FY2025 Results and ...

Continue Reading 0

us corporate news

BTCS Inc. Announces Change of Independent Registered Public Accounting Firm in 2026

Minichart

March 31, 2026

BTCS Inc. Announces Change in Independent Auditor BTCS...

Continue Reading 0